This inventor holds 1 USPTO granted patent. Top assignee: Fudan University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Leming Shi: Innovator in Human Immortalized B Lymphocyte Cell Lines
Introduction
Leming Shi is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biomedical research, particularly in the development of human immortalized B lymphocyte cell lines. His work has the potential to enhance the performance of various detection platforms in scientific research.
Latest Patents
Leming Shi holds a patent titled "Establishment and application of human immortalized B lymphocyte cell line group." This patent provides a group of human immortalized B lymphocyte cell lines and outlines their use. Specifically, it presents a combination of four closely related immortalized lymphocyte cell lines. This combination can serve as reference substances for measuring the performance of detection platforms. When utilized as reference substances for epigenome, transcriptome, proteome, and metabolome studies, these cell lines can create an intrinsic magnitude difference gradient. This gradient is essential for evaluating the sensitivity of histological detection.
Career Highlights
Leming Shi is affiliated with Fudan University, where he continues to advance his research in immunology and cell biology. His innovative work has garnered attention in the scientific community, contributing to the understanding of B lymphocyte functions and their applications in medical research.
Collaborations
Leming Shi collaborates with notable colleagues, including Li Zhong Jin and Wanwan Hou. These partnerships enhance the research efforts and broaden the impact of their findings in the field.
Conclusion
Leming Shi's contributions to the establishment of human immortalized B lymphocyte cell lines represent a significant advancement in biomedical research. His innovative patent and collaborative efforts at Fudan University highlight his commitment to improving detection methodologies in scientific studies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
